$19.24
+0.11(0.58%)
Mkt Cap $5.4B
$16.85
$39.30
52-Week Range
At a Glance
AI-generatedRevenue breakdown: Molecular Profiling Services (91.1%), Pharma Research And Development Services (8.9%).
8-K
Caris Life Sciences entered into a new $1.2 billion senior secured credit facility on April 1, 2026, and used a portion of the proceeds to repay all outstanding debt under its previous credit agreement.$5.4B
Market Cap
$137M
Revenue
-$12M
Net Income
Employees1,769
Fundamentals
How The Business Makes Money
Revenue by Segment
Molecular Profiling Services91.1%($2.8B)
Pharma Research And Development Services8.9%($272M)
Revenue by Geography
US97.8%($1.5B)
Non Us2.2%($34M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0002019410
ISINUS1421521071
CUSIP142152107
Phone866 771 8946
Address750 West John Carpenter Freeway, Irving, TX, 75039, US
SEC EDGAR